Can Diabetic Neuropathy Be Modeled In Vitro?

Int Rev Neurobiol. 2016:127:53-87. doi: 10.1016/bs.irn.2016.02.004. Epub 2016 Mar 28.

Abstract

Diabetic neuropathy is a common secondary complication of diabetes that impacts on patient's health and well-being. Distal axon degeneration is a key feature of diabetic neuropathy, but the pathological changes which underlie axonal die-back are incompletely understood; despite decades of research a treatment has not yet been identified. Basic research must focus on understanding the complex mechanisms underlying changes that occur in the nervous system during diabetes. To this end, tissue culture techniques are invaluable as they enable researchers to examine the intricate mechanistic responses of cells to high glucose or other factors in order to better understand the pathogenesis of nerve dysfunction. This chapter describes the use of in vitro models to study a wide range of specific cellular effects pertaining to diabetic neuropathy including apoptosis, neurite outgrowth, neurodegeneration, activity, and bioenergetics. We consider problems associated with in vitro modeling and future refinement such as use of induced pluripotent stem cells and microfluidic technology.

Keywords: DRG; Hyperglycemia; Neurite; Regeneration; Schwann cell; Sensory.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetic Neuropathies* / genetics
  • Diabetic Neuropathies* / pathology
  • Diabetic Neuropathies* / physiopathology
  • Disease Models, Animal*
  • Humans
  • In Vitro Techniques*